RESUMEN
Supraphysiological levels of the osteoblast-enriched mineralization regulator ectonucleotide pyrophosphatase or phosphodiesterase-1 (NPP1) is associated with type 2 diabetes mellitus. We determined the impact of osteoblast-specific Enpp1 ablation on skeletal structure and metabolic phenotype in mice. Female, but not male, 6-week-old mice lacking osteoblast NPP1 expression (osteoblast-specific knockout [KO]) exhibited increased femoral bone volume or total volume (17.50% vs. 11.67%; p < .01), and reduced trabecular spacing (0.187 vs. 0.157 mm; p < .01) compared with floxed (control) mice. Furthermore, an enhanced ability of isolated osteoblasts from the osteoblast-specific KO to calcify their matrix in vitro compared to fl/fl osteoblasts was observed (p < .05). Male osteoblast-specific KO and fl/fl mice showed comparable glucose and insulin tolerance despite increased levels of insulin-sensitizing under-carboxylated osteocalcin (195% increase; p < .05). However, following high-fat-diet challenge, osteoblast-specific KO mice showed impaired glucose and insulin tolerance compared with fl/fl mice. These data highlight a crucial local role for osteoblast NPP1 in skeletal development and a secondary metabolic impact that predominantly maintains insulin sensitivity.
Asunto(s)
Huesos/enzimología , Dieta Alta en Grasa/efectos adversos , Resistencia a la Insulina , Osteoblastos/enzimología , Osteogénesis , Hidrolasas Diéster Fosfóricas/deficiencia , Pirofosfatasas/deficiencia , Animales , Biomarcadores/sangre , Glucemia/metabolismo , Huesos/patología , Hueso Esponjoso/enzimología , Hueso Esponjoso/patología , Células Cultivadas , Modelos Animales de Enfermedad , Femenino , Fémur/enzimología , Fémur/patología , Insulina/sangre , Masculino , Ratones Noqueados , Osteoblastos/patología , Osteocalcina/sangre , Hidrolasas Diéster Fosfóricas/genética , Pirofosfatasas/genética , Factores Sexuales , Cráneo/enzimología , Cráneo/patología , Tibia/enzimología , Tibia/patologíaRESUMEN
Human urine-derived stem cells (hUSCs) serve as favorable candidates for bone transplants due to their efficient proliferative and multipotent differentiation abilities, as well as the capacity to secrete a variety of vasoactive agents to facilitate tissue engineering. The present study aimed to explore the role of focal adhesion kinase (FAK) in bone morphogenetic protein 2 (BMP2)-induced osteogenic differentiation of hUSCs and to investigate the underlying mechanism. The degree of osteogenic differentiation and the correlated signals, following BMP2 overexpression and siRNA-mediated silencing of FAK, were determined in vitro. Moreover, hUSCs induced bone formation in a rat model with cranial defects, in vivo. Our findings revealed that alkaline phosphatase production, calcium deposits, osteocalcin and osteopontin expression, and bone formation were upregulated in vitro and in vivo following BMP2-induced osteogenic differentiation, and AMPK and Wnt signaling pathway activation by FAK could effectively regulate BMP2-enhanced osteogenic differentiation of hUSCs. Taken together, these findings indicated that FAK could mediate BMP2-enhanced osteogenic differentiation of hUSCs through activating adenosine 5'-monophosphate-activated protein kinase and Wnt signaling pathways.
Asunto(s)
Proteínas Quinasas Activadas por AMP/metabolismo , Proteína Morfogenética Ósea 2/farmacología , Diferenciación Celular/efectos de los fármacos , Quinasa 1 de Adhesión Focal/metabolismo , Osteogénesis/efectos de los fármacos , Cráneo/enzimología , Células Madre/efectos de los fármacos , Vía de Señalización Wnt/efectos de los fármacos , Animales , Remodelación Ósea , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Quinasa 1 de Adhesión Focal/genética , Humanos , Hidrogeles , Ratas , Cráneo/diagnóstico por imagen , Cráneo/fisiopatología , Trasplante de Células Madre , Células Madre/enzimología , Andamios del Tejido , Orina/citologíaRESUMEN
Due to availability and ease of harvest, adipose tissue is a favorable source of progenitor cells in regenerative medicine, but has yet to be optimized for osteogenic differentiation. The purpose of this study was to test cranial bone healing in a surgical defect model utilizing bone morphogenetic protein-9 (BMP-9) transduced immortalized murine adipocyte (iMAD) progenitor cells in a citrate-based, phase-changing, poly(polyethylene glycol citrate-co-N-isopropylacrylamide) (PPCN)-gelatin scaffold. Mesenchymal progenitor iMAD cells were transduced with adenovirus expressing either BMP-9 or green fluorescent protein control. Twelve mice underwent craniectomy to achieve a critical-sized cranial defect. The iMAD cells were mixed with the PPCN-gelatin scaffold and injected into the defects. MicroCT imaging was performed in 2-week intervals for 12 weeks to track defect healing. Histologic analysis was performed on skull sections harvested after the final imaging at 12 weeks to assess quality and maturity of newly formed bone. Both the BMP-9 group and control group had similar initial defect sizes (Pâ=â0.21). At each time point, the BMP-9 group demonstrated smaller defect size, higher percentage defect healed, and larger percentage defect change over time. At the end of the 12-week period, the BMP-9 group demonstrated mean defect closure of 27.39%, while the control group showed only a 9.89% defect closure (Pâ<â0.05). The BMP-9-transduced iMADs combined with a PPCN-gelatin scaffold promote in vivo osteogenesis and exhibited significantly greater osteogenesis compared to control. Adipose-derived iMADs are a promising source of mesenchymal stem cells for further studies in regenerative medicine, specifically bone engineering with the aim of potential craniofacial applications.
Asunto(s)
Adipocitos/enzimología , Metaloproteinasa 9 de la Matriz/metabolismo , Células Madre Mesenquimatosas/enzimología , Nanocompuestos , Cráneo/enzimología , Animales , Línea Celular , Humanos , Metaloproteinasa 9 de la Matriz/genética , Células Madre Mesenquimatosas/citología , Ratones , Osteogénesis , Células Madre/citología , Microtomografía por Rayos XRESUMEN
Abstract This study aimed to investigate the influence of a three-dimensional cell culture model and bioactive glass (BG) particles on the expression of osteoblastic phenotypes in rat calvaria osteogenic cells culture. Cells were seeded on two-dimensional (2D) and three-dimensional (3D) collagen with BG particles for up to 14 days. Cell viability and alkaline phosphatase (ALP) activity was performed. Cell morphology and immunolabeling of noncollagenous bone matrix proteins were assessed by epifluorescence and confocal microscopy. The expressions of osteogenic markers were analyzed using RT-PCR. Mineralized bone-like nodule formation was visualized by microscopy and calcium content was assessed quantitatively by alizarin red assay. Experimental cultures produced a growing cell viability rate up to 14 days. Although ALP activity at 7 days was higher on BG cultures, cells on 3D and 3D+BG had an activity decrease of ALP at 14 days. Three-dimensional conditions favored the immunolabeling for OPN and BSP and the expression of ALP and COL I mRNAs. BG particles influenced positively the OC and OPN mRNAs expression and calcified nodule formation in vitro. The results indicated that the 3D cultures and BG particles contribute to the expression of osteoblastic phenotype and to differentiated and mineralized matrix formation.
Resumo O objetivo deste estudo foi investigar a influência do modelo de cultura celular tridimensional e das partículas de vidro bioativo (BG) sobre a expressão fenotípica de culturas de células osteogênicas da calvária de ratos. As células foram mantidas em culturas sobre superfícies colágenas bi-dimensionais (2D) e em géis de colágeno tridimensional (3D) com e sem partículas de BG até 14 dias. Foram avaliadas: viabilidade celular, atividade de fosfatase alcalina (ALP), morfologia celular e imunomarcação de proteínas da matriz não-colágena do osso através de epifluorescência e microscopia confocal. As expressões de marcadores osteogênicos foram analisadas utilizando RT-PCR. A formação de nódulos mineralizados foi visualizada através de microscopia e o conteúdo de cálcio foi avaliado quantitativamente pelo Alizarina Red. As culturas experimentais produziram uma taxa crescente de viabilidade até 14 dias. Embora a atividade ALP em 7 dias tenha sido maior em culturas com BG, as células em 3D e 3D+BG apresentaram uma diminuição da atividade ALP aos 14 dias. As condições tridimensionais favoreceram a imunomarcação para OPN e BSP e a expressão de mRNAs para ALP e COL I. As partículas de BG influenciaram positivamente a expressão do mRNAs para OPN e OC e a formação de nódulos calcificados in vitro. Os resultados indicaram que as culturas em 3D e partículas BG contribuíram para a expressão do fenótipo osteoblástico e para a diferenciação e formação de matriz mineralizada.
Asunto(s)
Animales , Materiales Biocompatibles , Vidrio , Osteoblastos/citología , Osteogénesis , Cráneo/citología , Fosfatasa Alcalina/genética , Fosfatasa Alcalina/metabolismo , Biomarcadores/metabolismo , Calcio/metabolismo , Técnicas de Cultivo de Célula , Supervivencia Celular , Colágeno Tipo I/genética , Colágeno Tipo I/metabolismo , Técnica del Anticuerpo Fluorescente Indirecta , Perfilación de la Expresión Génica , Sialoproteína de Unión a Integrina/metabolismo , Microscopía Confocal , Microscopía Fluorescente , Osteoblastos/enzimología , Osteoblastos/metabolismo , Osteopontina/metabolismo , Ratas Wistar , Reacción en Cadena en Tiempo Real de la Polimerasa , ARN Mensajero/genética , Cráneo/enzimología , Cráneo/metabolismo , Andamios del TejidoRESUMEN
This study aimed to investigate the influence of a three-dimensional cell culture model and bioactive glass (BG) particles on the expression of osteoblastic phenotypes in rat calvaria osteogenic cells culture. Cells were seeded on two-dimensional (2D) and three-dimensional (3D) collagen with BG particles for up to 14 days. Cell viability and alkaline phosphatase (ALP) activity was performed. Cell morphology and immunolabeling of noncollagenous bone matrix proteins were assessed by epifluorescence and confocal microscopy. The expressions of osteogenic markers were analyzed using RT-PCR. Mineralized bone-like nodule formation was visualized by microscopy and calcium content was assessed quantitatively by alizarin red assay. Experimental cultures produced a growing cell viability rate up to 14 days. Although ALP activity at 7 days was higher on BG cultures, cells on 3D and 3D+BG had an activity decrease of ALP at 14 days. Three-dimensional conditions favored the immunolabeling for OPN and BSP and the expression of ALP and COL I mRNAs. BG particles influenced positively the OC and OPN mRNAs expression and calcified nodule formation in vitro. The results indicated that the 3D cultures and BG particles contribute to the expression of osteoblastic phenotype and to differentiated and mineralized matrix formation.
Asunto(s)
Materiales Biocompatibles , Vidrio , Osteoblastos/citología , Osteogénesis , Cráneo/citología , Fosfatasa Alcalina/genética , Fosfatasa Alcalina/metabolismo , Animales , Biomarcadores/metabolismo , Calcio/metabolismo , Técnicas de Cultivo de Célula , Supervivencia Celular , Colágeno Tipo I/genética , Colágeno Tipo I/metabolismo , Técnica del Anticuerpo Fluorescente Indirecta , Perfilación de la Expresión Génica , Sialoproteína de Unión a Integrina/metabolismo , Microscopía Confocal , Microscopía Fluorescente , Osteoblastos/enzimología , Osteoblastos/metabolismo , Osteopontina/metabolismo , ARN Mensajero/genética , Ratas Wistar , Reacción en Cadena en Tiempo Real de la Polimerasa , Cráneo/enzimología , Cráneo/metabolismo , Andamios del TejidoRESUMEN
Aseptic loosening is associated with the development of wear debris-induced peri-implant osteolytic bone disease caused by an increased osteoclastic bone resorption and decreased osteoblastic bone formation. However, no effective measures for the prevention and treatment of peri-implant osteolysis currently exist. The aim of this study was to determine whether lithium chloride (LiCl), a selective inhibitor of glycogen synthetase kinase 3 beta (GSK-3ß), mitigates wear debris-induced osteolysis in a murine calvarial model of osteolysis. GSK-3ß is activated by titanium (Ti) particles, and implantation of Ti particles on the calvarial surface in C57BL/6 mice resulted in osteolysis caused by an increase in the number of osteoclasts and a decrease in the number of osteoblasts. Mice implanted with Ti particles were gavage-fed LiCl (50 or 200 mg kg(-1)d(-1)), 6 days per week for 2 weeks. The LiCl treatment significantly inhibited GSK-3ß activity and increased ß-catenin and axin-2 expression in a dose-dependent manner, dramatically mitigating the Ti particle-induced suppression of osteoblast numbers and the expression of bone formation markers. Finally, we demonstrated that inhibition of GSK-3ß suppresses osteoclast differentiation and reduces the severity of Ti particle-induced osteolysis. The results of this study indicate that Ti particle-induced osteolysis is partly dependent on GSK-3ß and, therefore, the canonical Wnt signaling pathway. This suggests that selective inhibitors of GSK-3ß such as LiCl may help prevent and treat wear debris-induced osteolysis.
Asunto(s)
Glucógeno Sintasa Quinasa 3/antagonistas & inhibidores , Cloruro de Litio/uso terapéutico , Osteólisis/tratamiento farmacológico , Osteólisis/enzimología , Inhibidores de Proteínas Quinasas/uso terapéutico , Animales , Femenino , Glucógeno Sintasa Quinasa 3/metabolismo , Glucógeno Sintasa Quinasa 3 beta , Ratones , Ratones Endogámicos C57BL , Osteólisis/etiología , Osteólisis/patología , Prótesis e Implantes/efectos adversos , Cráneo/efectos de los fármacos , Cráneo/enzimología , Cráneo/patología , Titanio/efectos adversosRESUMEN
Holoprosencephaly is a common developmental disorder in humans characterised by incomplete brain hemisphere separation and midface anomalies. The etiology of holoprosencephaly is heterogeneous with environmental and genetic causes, but for a majority of holoprosencephaly cases the genes associated with the pathogenesis could not be identified so far. Here we report the generation of knockout mice for the ubiquitin E3 ligase NOSIP. The loss of NOSIP in mice causes holoprosencephaly and facial anomalies including cleft lip/palate, cyclopia and facial midline clefting. By a mass spectrometry based protein interaction screen we identified NOSIP as a novel interaction partner of protein phosphatase PP2A. NOSIP mediates the monoubiquitination of the PP2A catalytic subunit and the loss of NOSIP results in an increase in PP2A activity in craniofacial tissue in NOSIP knockout mice. We conclude, that NOSIP is a critical modulator of brain and craniofacial development in mice and a candidate gene for holoprosencephaly in humans.
Asunto(s)
Cara/embriología , Proteína Fosfatasa 2/metabolismo , Cráneo/embriología , Cráneo/enzimología , Ubiquitina-Proteína Ligasas/metabolismo , Animales , Animales Recién Nacidos , Dominio Catalítico , Fisura del Paladar/embriología , Fisura del Paladar/enzimología , Cara/anomalías , Holoprosencefalia/embriología , Holoprosencefalia/enzimología , Holoprosencefalia/patología , Metilación , Ratones Endogámicos C57BL , Ratones Noqueados , Unión Proteica , Cráneo/anomalías , UbiquitinaciónRESUMEN
Pregnancy-associated plasma protein A2 (PAPP-A2, also known as pappalysin-2) is a large metalloproteinase that is known to be required for normal postnatal growth and bone development in mice. We here report the detection of zebrafish papp-a2 mRNA in the chordamesoderm, notochord and lower jaw of zebrafish (Danio rerio) embryos, and that papp-a2-knockdown embryos display broadened axial mesoderm, notochord bends and severely reduced cranial cartilages. Genetic data link these phenotypes to insulin-like growth factor (Igf)-binding protein-3 (Igfbp-3) and bone morphogenetic protein (Bmp) signaling, and biochemical analysis show specific Igfbp-3 proteolysis by Papp-a2, implicating Papp-a2 in the modulation of Bmp signaling by Igfbp-3 proteolysis. Knockdown of papp-a2 additionally resulted in angiogenesis defects, strikingly similar to previous observations in embryos with mutations in components of the Notch system. Accordingly, we find that Notch signaling is modulated by Papp-a2 in vivo, and, furthermore, that human PAPP-A2 is capable of modulating Notch signaling independently of its proteolytic activity in cell culture. Based on these results, we conclude that Papp-a2 modulates Bmp and Notch signaling by independent mechanisms in zebrafish embryos. In conclusion, these data link pappalysin function in zebrafish to two different signaling pathways outside the IGF system.
Asunto(s)
Cartílago/enzimología , Neovascularización Fisiológica , Proteína Plasmática A Asociada al Embarazo/metabolismo , Cráneo/enzimología , Proteínas de Pez Cebra/metabolismo , Pez Cebra/metabolismo , Secuencia de Aminoácidos , Animales , Proteínas Morfogenéticas Óseas/genética , Proteínas Morfogenéticas Óseas/metabolismo , Cartílago/embriología , Regulación del Desarrollo de la Expresión Génica , Regulación Enzimológica de la Expresión Génica , Técnicas de Silenciamiento del Gen , Genotipo , Células HEK293 , Humanos , Proteína 3 de Unión a Factor de Crecimiento Similar a la Insulina/metabolismo , Proteína 4 de Unión a Factor de Crecimiento Similar a la Insulina/metabolismo , Datos de Secuencia Molecular , Fenotipo , Proteína Plasmática A Asociada al Embarazo/genética , ARN Mensajero/metabolismo , Receptores Notch/genética , Receptores Notch/metabolismo , Transducción de Señal , Cráneo/embriología , Factores de Tiempo , Transfección , Pez Cebra/embriología , Pez Cebra/genética , Proteínas de Pez Cebra/genéticaRESUMEN
While it has been well-documented that excessive fluoride exposure caused the skeletal disease and osteoblasts played a critical role in the advanced skeletal fluorosis, the underlying mechanism that mediated these effects remain poorly understood. The present study was undertaken to examine the effect of fluoride on bone of rats and MC3T3-E1 cells in vitro. Herein we found pathological features of high bone turnover in fluoride-treated rats, which was supported by an increase of osteogenic and osteoclastogenic genes expression in different stages of fluoride exposure. The skeletal toxicity of fluoride was accompanied by activation of endoplasmic reticulum (ER) stress and subsequent unfolded protein response (UPR). A novel finding of this study was that expression of PKR-like endoplasmic reticulum kinase (PERK) was the same trend with receptor activator for nuclear factor-κ B ligand (RANKL), and NF-E2 p45-related factor 2 (Nrf2) was the same trend with Runt-related transcription factor 2 (Runx2) in bones of rats exposed to varied fluoride condition. Based on these data, we hypothesized that up-regulation of PERK probably played a role in mediating bone turnover induced by fluoride. Action of fluoride on MC3T3-E1 cells differentiation was demonstrated through analysis of alkaline phosphatase (ALP) activity and mineralized nodules formation. Meantime, an increase of binding immunoglobulin protein (BiP) expression indicated the active ER stress in cells exposed to various dose of fluoride. Blocking PERK expression using siRNA showed the obvious decrease of osteogenic and osteoclastogenic factors expression in MC3T3-E1 cells exposed to certain dose of fluoride that could positively stimulate osteoblastic viability. In conclusion these findings underscore the importance of PERK in modulating fluoride induced bone formation and bone resorption. Understanding the link between PERK and bone turnover could probe into the mechanism underlying different bone lesion of skeletal fluorosis.
Asunto(s)
Remodelación Ósea/efectos de los fármacos , Fémur/efectos de los fármacos , Osteoblastos/efectos de los fármacos , Osteoclastos/efectos de los fármacos , Cráneo/efectos de los fármacos , Fluoruro de Sodio/toxicidad , eIF-2 Quinasa/metabolismo , Animales , Densidad Ósea/efectos de los fármacos , Remodelación Ósea/genética , Diferenciación Celular/efectos de los fármacos , Línea Celular , Estrés del Retículo Endoplásmico/efectos de los fármacos , Fémur/enzimología , Fémur/patología , Regulación de la Expresión Génica/efectos de los fármacos , Marcadores Genéticos , Masculino , Ratones Endogámicos C57BL , Osteoblastos/enzimología , Osteoblastos/patología , Osteoclastos/enzimología , Osteoclastos/patología , Interferencia de ARN , Ratas Wistar , Transducción de Señal/efectos de los fármacos , Cráneo/enzimología , Cráneo/patología , Factores de Tiempo , Transfección , eIF-2 Quinasa/genéticaRESUMEN
FGFR3 gain-of-function mutations lead to both chondrodysplasias and craniosynostoses. Achondroplasia (ACH), the most frequent dwarfism, is due to an FGFR3-activating mutation which results in impaired endochondral ossification. The effects of the mutation on membranous ossification are unknown. Fgfr3(Y367C/+) mice mimicking ACH and craniofacial analysis of patients with ACH and FGFR3-related craniosynostoses provide an opportunity to address this issue. Studying the calvaria and skull base, we observed abnormal cartilage and premature fusion of the synchondroses leading to modifications of foramen magnum shape and size in Fgfr3(Y367C/+) mice, ACH and FGFR3-related craniosynostoses patients. Partial premature fusion of the coronal sutures and non-ossified gaps in frontal bones were also present in Fgfr3(Y367C/+) mice and ACH patients. Our data provide strong support that not only endochondral ossification but also membranous ossification is severely affected in ACH. Demonstration of the impact of FGFR3 mutations on craniofacial development should initiate novel pharmacological and surgical therapeutic approaches.
Asunto(s)
Acondroplasia/enzimología , Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos/genética , Acondroplasia/genética , Acondroplasia/patología , Animales , Condrocitos/citología , Condrocitos/enzimología , Femenino , Humanos , Lactante , Masculino , Ratones , Ratones Transgénicos , Mutación Missense , Osificación Heterotópica , Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos/metabolismo , Cráneo/anatomía & histología , Cráneo/embriología , Cráneo/enzimología , Cráneo/patologíaRESUMEN
Intracellular protein delivery is a novel tool for functional analysis of protein inside a cell. Several protein delivery reagents with diverse mechanisms have been developed and are commercially available. In this study, we focused on the inhibitory effect of intracellular delivery of SMAD ubiquitination regulation factor 1 (SMURF1) on the recombinant human bone morphogenetic protein-2 (rhBMP-2) signaling pathway. First, three commercially available reagents for intracellular delivery (BioPORTER(®), PULSin(®), and Xfect(TM)) were tested in a murine preosteoblast cell line, MC3T3-E1.4. The biocompatibility of these reagents was examined by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium assay and the cellular uptake and delivery efficiency were determined with FITC-antibody and ß-galactosidase (ß-gal), respectively. BioPORTER(®) provided the best results and was, therefore, chosen for the second aspect of our study: intracellular SMURF1 delivery. SMURF1/BioPORTER(®) complexes were applied to cells prior to rhBMP-2 application. The outcome data suggest intracellular SMURF1 delivery in MC3T3-E1.4 cells significantly inhibited alkaline phosphatase upregulation. This outcome may be useful to off-targets effects of rhBMP-2.
Asunto(s)
Fosfatasa Alcalina/biosíntesis , Proteína Morfogenética Ósea 2/farmacología , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Osteoblastos/enzimología , Cráneo/enzimología , Células Madre/enzimología , Ubiquitina-Proteína Ligasas/farmacología , Fosfatasa Alcalina/genética , Animales , Proteína Morfogenética Ósea 2/genética , Línea Celular , Humanos , Ratones , Osteoblastos/citología , Proteínas Recombinantes/genética , Proteínas Recombinantes/farmacología , Cráneo/citología , Células Madre/citología , Ubiquitina-Proteína Ligasas/genética , Regulación hacia Arriba/efectos de los fármacosRESUMEN
Glycogen Synthase Kinase 3 (GSK-3) is a key player in development, physiology and disease. Because of this, GSK-3 inhibitors are increasingly being explored for a variety of applications. In addition most analyses focus on GSK-3ß and overlook the closely related protein GSK-3α. Here, we describe novel GSK-3α and GSK-3ß mouse alleles that allow us to visualise expression of their respective mRNAs by tracking ß-galactosidase activity. We used these new lacZ alleles to compare expression in the palate and cranial sutures and found that there was indeed differential expression. Furthermore, both are loss of function alleles and can be used to generate homozygous mutant mice; in addition, excision of the lacZ cassette from GSK-3α creates a Cre-dependent tissue-specific knockout. As expected, GSK3α mutants were viable, while GSK3ß mutants died after birth with a complete cleft palate. We also assessed the GSK-3α mutants for cranial and sternal phenotypes and found that they were essentially normal. Finally, we observed gestational lethality in compound GSK-3ß(-/-); GSK3α(+/-) mutants, suggesting that GSK-3 dosage is critical during embryonic development.
Asunto(s)
Fisura del Paladar/genética , Glucógeno Sintasa Quinasa 3/genética , Hueso Paladar/enzimología , ARN Mensajero/biosíntesis , Cráneo/enzimología , Alelos , Animales , Fisura del Paladar/enzimología , Fisura del Paladar/patología , Embrión de Mamíferos , Desarrollo Embrionario , Femenino , Dosificación de Gen , Expresión Génica , Genes Reporteros , Glucógeno Sintasa Quinasa 3/metabolismo , Glucógeno Sintasa Quinasa 3 beta , Heterocigoto , Homocigoto , Integrasas/genética , Integrasas/metabolismo , Ratones , Ratones Transgénicos , Mutación , Hueso Paladar/patología , Embarazo , ARN Mensajero/genética , Cráneo/patología , beta-GalactosidasaRESUMEN
The neural crest is a population of multipotent cells that migrates extensively throughout vertebrate embryos to form diverse structures. Mice mutant for the de novo DNA methyltransferase DNMT3b exhibit defects in two neural crest derivatives, the craniofacial skeleton and cardiac ventricular septum, suggesting that DNMT3b activity is necessary for neural crest development. Nevertheless, the requirement for DNMT3b specifically in neural crest cells, as opposed to interacting cell types, has not been determined. Using a conditional DNMT3b allele crossed to the neural crest cre drivers Wnt1-cre and Sox10-cre, neural crest DNMT3b mutants were generated. In both neural crest-specific and fully DNMT3b-mutant embryos, cranial neural crest cells exhibited only subtle migration defects, with increased numbers of dispersed cells trailing organized streams in the head. In spite of this, the resulting cranial ganglia, craniofacial skeleton, and heart developed normally when neural crest cells lacked DNMT3b. This indicates that DNTM3b is not necessary in cranial neural crest cells for their development. We conclude that defects in neural crest derivatives in DNMT3b mutant mice reflect a requirement for DNMT3b in lineages such as the branchial arch mesendoderm or the cardiac mesoderm that interact with neural crest cells during formation of these structures.
Asunto(s)
ADN (Citosina-5-)-Metiltransferasas/genética , Regulación del Desarrollo de la Expresión Génica , Cresta Neural/enzimología , Neurogénesis/genética , Animales , Ganglios Basales/embriología , Ganglios Basales/enzimología , Región Branquial/embriología , Región Branquial/enzimología , Diferenciación Celular , Movimiento Celular , ADN (Citosina-5-)-Metiltransferasas/metabolismo , Embrión de Mamíferos , Corazón/embriología , Integrasas/genética , Integrasas/metabolismo , Mesodermo/embriología , Mesodermo/enzimología , Ratones , Ratones Transgénicos , Mutación , Cresta Neural/embriología , Factores de Transcripción SOXE/genética , Factores de Transcripción SOXE/metabolismo , Cráneo/embriología , Cráneo/enzimología , Proteína Wnt1/genética , Proteína Wnt1/metabolismo , ADN Metiltransferasa 3BRESUMEN
OBJECT: Although bone invasion and hyperostosis are common phenomena in patients with intracranial meningiomas, the basic pathomechanism is not fully understood. Based on an immunohistochemical study of surgically resected samples with hyperostosis, we postulate a possible mechanism of hyperostosis in patients with intracranial meningiomas. MATERIALS AND METHODS: Forty-six meningiomas were evaluated in this study. Twenty-six meningiomas associated with hyperostosis specimens served as the study group, and 20 meningiomas without any bony changes served as controls. An immunohistochemical staining technique was used to detect the expression of matrix metalloproteinase (MMP)-2, -9, and -13, membrane type (MT)1-MMP, estrogen receptor (ER), and progesterone receptor (PR) in the main tumor and hyperostotic portions of the studied samples. RESULTS: In the non-hyperostosis group, expression of MMP-13, MT1-MMP, and ER was significantly less than in the main tumor portion of hyperostotic meningiomas, while there was no difference in the expression of MMP-2 and -9 and PR in the main tumor between the two groups. In the hyperostosis group, the immunoreactivity of MMP-2 in the hyperostotic portion revealed a higher pattern of expression than the main tumor (p < 0.002). The expression of MMP-9, MT1-MMP, ER, and PR had relatively positive immunoreactivity in the main tumor portion (P < 0.05). CONCLUSIONS: Increased expression of MMP-13 and MT1-MMP in the tumor portion of hyperostosis of meningiomas might contribute to the initiation of osteolysis. Activated MMP-2 in hyperostotic lesions may change the physiological metabolism of the skull bone, thus playing an important role in hyperostosis formation.
Asunto(s)
Hiperostosis/enzimología , Metaloproteinasas de la Matriz/fisiología , Neoplasias Meníngeas/enzimología , Meningioma/enzimología , Cráneo/enzimología , Biomarcadores de Tumor/fisiología , Femenino , Humanos , Hiperostosis/patología , Hiperostosis/fisiopatología , Masculino , Metaloproteinasa 13 de la Matriz/fisiología , Metaloproteinasa 14 de la Matriz/fisiología , Metaloproteinasa 2 de la Matriz/fisiología , Metaloproteinasa 9 de la Matriz/fisiología , Neoplasias Meníngeas/patología , Neoplasias Meníngeas/fisiopatología , Meningioma/patología , Meningioma/fisiopatología , Invasividad Neoplásica/patología , Invasividad Neoplásica/fisiopatología , Osteólisis/enzimología , Osteólisis/patología , Osteólisis/fisiopatología , Cráneo/patología , Cráneo/fisiopatologíaRESUMEN
In human prostate to bone metastases and in a novel rodent model that recapitulates prostate tumor-induced osteolytic and osteogenic responses, we found that osteoclasts are a major source of the proteinase, matrix metalloproteinase (MMP)-9. Because MMPs are important mediators of tumor-host communication, we tested the effect of host-derived MMP-9 on prostate tumor progression in the bone. To this end, immunocompromised mice that were wild-type or null for MMP-9 received transplants of osteolytic/osteogenic-inducing prostate adenocarcinoma tumor tissue to the calvaria. Surprisingly, we found that that host MMP-9 significantly contributed to prostate tumor growth without affecting prostate tumor-induced osteolytic or osteogenic change as determined by microcomputed tomography, microsingle-photon emission computed tomography, and histomorphometry. Subsequent studies aimed at delineating the mechanism of MMP-9 action on tumor growth focused on angiogenesis because MMP-9 and osteoclasts have been implicated in this process. We observed (a) significantly fewer and smaller blood vessels in the MMP-9 null group by CD-31 immunohistochemistry; (b) MMP-9 null osteoclasts had significantly lower levels of bioavailable vascular endothelial growth factor-A(164); and (c) using an aorta sprouting assay, conditioned media derived from wild-type osteoclasts was significantly more angiogenic than conditioned media derived from MMP-9 null osteoclasts. In conclusion, these studies show that osteoclast-derived MMP-9 affects prostate tumor growth in the bone microenvironment by contributing to angiogenesis without altering prostate tumor-induced osteolytic or osteogenic changes.
Asunto(s)
Adenocarcinoma/sangre , Metaloproteinasa 9 de la Matriz/genética , Metástasis de la Neoplasia/fisiopatología , Neovascularización Patológica/enzimología , Osteoclastos/enzimología , Neoplasias de la Próstata/irrigación sanguínea , Adenocarcinoma/metabolismo , Adenocarcinoma/fisiopatología , Animales , Proliferación Celular , Células Cultivadas , Medios de Cultivo Condicionados/farmacología , Supervivencia de Injerto/fisiología , Masculino , Metaloproteinasa 9 de la Matriz/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Invasividad Neoplásica/fisiopatología , Trasplante de Neoplasias , Neovascularización Patológica/genética , Neovascularización Patológica/fisiopatología , Osteoclastos/metabolismo , Osteogénesis/fisiología , Neoplasias de la Próstata/metabolismo , Neoplasias de la Próstata/fisiopatología , Ratas , Cráneo/citología , Cráneo/enzimología , Cráneo/cirugía , Células Tumorales Cultivadas , Factor A de Crecimiento Endotelial Vascular/metabolismoRESUMEN
Increased osteoclastogenesis and angiogenesis occur in physiologic and pathologic conditions. However, it is unclear if or how these processes are linked. To test the hypothesis that osteoclasts stimulate angiogenesis, we modulated osteoclast formation in fetal mouse metatarsal explants or in adult mice and determined the effect on angiogenesis. Suppression of osteoclast formation with osteoprotegerin dose-dependently inhibited angiogenesis and osteoclastogenesis in metatarsal explants. Conversely, treatment with parathyroid hormone related protein (PTHrP) increased explant angiogenesis, which was completely blocked by osteoprotegerin. Further, treatment of mice with receptor activator of nuclear factor-kappaB ligand (RANKL) or PTHrP in vivo increased calvarial vessel density and osteoclast number. We next determined whether matrix metalloproteinase-9 (MMP-9), an angiogenic factor predominantly produced by osteoclasts in bone, was important for osteoclast-stimulated angiogenesis. The pro-angiogenic effects of PTHrP or RANKL were absent in metatarsal explants or calvaria in vivo, respectively, from Mmp9(-/-) mice, demonstrating the importance of MMP-9 for osteoclast-stimulated angiogenesis. Lack of MMP-9 decreased osteoclast numbers and abrogated angiogenesis in response to PTHrP or RANKL in explants and in vivo but did not decrease osteoclast differentiation in vitro. Thus, MMP-9 modulates osteoclast-stimulated angiogenesis primarily by affecting osteoclasts, most probably by previously reported migratory effects on osteoclasts. These results clearly demonstrate that osteoclasts stimulate angiogenesis in vivo through MMP-9.
Asunto(s)
Huesos Metatarsianos/irrigación sanguínea , Neovascularización Fisiológica , Osteoclastos/fisiología , Inductores de la Angiogénesis/metabolismo , Animales , Femenino , Feto/irrigación sanguínea , Feto/efectos de los fármacos , Humanos , Masculino , Metaloproteinasa 9 de la Matriz/deficiencia , Metaloproteinasa 9 de la Matriz/genética , Metaloproteinasa 9 de la Matriz/metabolismo , Huesos Metatarsianos/efectos de los fármacos , Huesos Metatarsianos/embriología , Ratones , Ratones Endogámicos C57BL , Modelos Biológicos , Neovascularización Fisiológica/efectos de los fármacos , Osteoclastos/efectos de los fármacos , Osteoclastos/enzimología , Proteína Relacionada con la Hormona Paratiroidea/farmacología , Ligando RANK/farmacología , Cráneo/citología , Cráneo/efectos de los fármacos , Cráneo/enzimología , Regulación hacia Arriba/efectos de los fármacosRESUMEN
BACKGROUND: Human mesenchymal stem cells (hMSCs) are multipotent stem cells found in the adult bone marrow that have the capacity to differentiate into various mesenchymal cell types. The hMSCs may provide a potential therapy to restore damaged tissues or organs of mesenchymal origin; however, a drawback is their limited life span in vitro. METHODS: We immortalized normal hMSCs with retrovirally transmitted human telomerase reverse transcriptase cDNA. One of the immortalized clones (YKNK-12) was established, and the biological characteristics were investigated in vitro and in vivo. RESULTS: YKNK-12 cells were capable of differentiating adipocytes, osetoblasts, and chondrocytes. Osteogenically differentiated YKNK-12 cells produced significant levels of growth factors BMP4, BMP6, FGF6, FGF7, transforming growth factor-beta1, and transforming growth factor-beta3.. Microcomputer tomography T and soft X-ray assays showed an excellent calvarial bone healing in mice after transplantation of osteogenically differentiated YKNK-12 cells. These cells expressed human-specific osteocalcin and increased the gene expression of runt-related transcription factor 2, alkaline phosphatase, osteocalcin, and osterix in the bone regenerating area. YKNK-12 cell transplant corrected the bone defect without inducing any adverse effects. CONCLUSIONS: We conclude that hMSCs immortalized by transduction with human telomerase reverse transcriptase may provide an unlimited source of cells for therapeutic use in bone regeneration.
Asunto(s)
Enfermedades Óseas/cirugía , Regeneración Ósea , Trasplante de Células Madre Mesenquimatosas , Células Madre Mesenquimatosas/enzimología , Osteogénesis , Cráneo/cirugía , Telomerasa/metabolismo , Adipocitos/enzimología , Animales , Biomarcadores/metabolismo , Enfermedades Óseas/diagnóstico por imagen , Enfermedades Óseas/enzimología , Enfermedades Óseas/fisiopatología , Diferenciación Celular , Línea Celular Transformada , Linaje de la Célula , Proliferación Celular , Supervivencia Celular , Condrocitos/enzimología , Modelos Animales de Enfermedad , Femenino , Humanos , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Ratones , Ratones Endogámicos BALB C , Osteoblastos/enzimología , Radiografía , Cráneo/diagnóstico por imagen , Cráneo/enzimología , Cráneo/fisiopatología , Telomerasa/genética , Factores de Tiempo , Transducción GenéticaRESUMEN
It has been reported that TNF-alpha plays an important role in bone resorption in pathological conditions. IL-12, which is a T cell mediator, is also an important inflammatory cytokine. We previously reported that IL-12 induces apoptosis in bone marrow cells treated with TNF-alpha in vitro via an interaction between TNF-alpha-induced Fas and IL-12-induced Fas ligand (FasL), and that, as a result, osteoclastogenesis is inhibited. The purpose of this study was to investigate the effects of IL-12 on TNF-alpha-mediated osteoclastogenesis in vivo. We administered TNF-alpha with and without IL-12 into the supracalvaria in mice. The numbers of osteoclasts in the sutures in the calvaria were higher in mice administered TNF-alpha than in control mice not administered TNF-alpha. The numbers of osteoclasts in mice administered both TNF-alpha and IL-12 were lower than those in mice administered only TNF-alpha. Next, we determined the levels of mRNAs for cathepsin K and tartrate-resistant acid phosphatase (TRAP). mRNA levels were increased in mice administered TNF-alpha compared with control mice, but not in mice administered both TNF-alpha and IL-12. We also evaluated the amounts of tartrate-resistant acid phosphatase 5b (TRACP 5b) in mouse sera. The levels of TRACP 5b in mice administered TNF-alpha were higher than those in control mice. On the other hand, in mice administered both TNF-alpha and IL-12, the levels were lower than those in mice administered TNF-alpha alone. Fas and FasL expression levels were analyzed by real-time RT-PCR. The levels of Fas mRNA were increased in the calvaria of mice administered TNF-alpha compared with control mice, while those of FasL mRNAs were increased in the calvaria of mice administered IL-12. In TdT-mediated dUTP-biotin nick end-labeling (TUNEL) assays, many apoptotic cells were found in the sutures in the calvaria of mice administered both TNF-alpha and IL-12. IL-12 also inhibited TNF-alpha-induced osteoclastogenesis in mice whose T cells were blocked by anti-CD4 and anti-CD8 antibodies. These results suggest that IL-12 inhibits TNF-alpha-mediated osteoclastogenesis and induces apoptotic changes through an interaction between TNF-alpha-induced Fas and IL-12-induced FasL, in vivo, via a T cell-independent mechanism.
Asunto(s)
Interleucina-12/farmacología , Osteoclastos/citología , Osteoclastos/efectos de los fármacos , Osteogénesis/efectos de los fármacos , Factor de Necrosis Tumoral alfa/farmacología , Fosfatasa Ácida/genética , Fosfatasa Ácida/metabolismo , Animales , Apoptosis/efectos de los fármacos , Células de la Médula Ósea/citología , Células de la Médula Ósea/efectos de los fármacos , Catepsina K/genética , Catepsina K/metabolismo , Proteína Ligando Fas/genética , Proteína Ligando Fas/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Interleucina-12/administración & dosificación , Isoenzimas/genética , Isoenzimas/metabolismo , Depleción Linfocítica , Ratones , Ratones Endogámicos C57BL , Ratones Desnudos , Osteoclastos/enzimología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Cráneo/citología , Cráneo/efectos de los fármacos , Cráneo/enzimología , Linfocitos T/efectos de los fármacos , Linfocitos T/metabolismo , Fosfatasa Ácida Tartratorresistente , Factor de Necrosis Tumoral alfa/administración & dosificación , Receptor fas/genética , Receptor fas/metabolismoRESUMEN
The small GTPase Rho and Rho-associated protein kinase (Rho kinase, ROCK) signal participates in a variety of biological functions including vascular contraction, tumor invasion, and penile erection. Evidence also suggests Rho-ROCK is involved in signaling for mesenchymal cellular differentiation. However, whether it is involved in osteoblastic differentiation is unknown. We therefore asked whether Rho-ROCK signaling participates in recombinant human bone morphogenetic protein (rhBMP-2)-induced osteogenesis both in vitro and in vivo. Continuous delivery of a specific ROCK inhibitor (Y-27632) enhanced ectopic bone formation induced by rhBMP-2 impregnated into an atelocollagen carrier in mice without affecting systemic bone metabolism. Treatment with Y-27632 also enhanced the osteoblastic differentiation of cultured murine neonatal calvarial cells. These effects were associated with increased expression of BMP-4 gene. Expression of a dominant negative mutant of ROCK in ST2 cells promoted osteoblastic differentiation, while a constitutively active mutant of ROCK attenuated osteoblastic differentiation and the ROCK inhibitor reversed this phenotype. Thus, ROCK inhibits osteogenesis, and a ROCK inhibitor in combination with the local delivery of rhBMP/collagen composite may be clinically applicable for stimulating bone formation.
Asunto(s)
Amidas/administración & dosificación , Proteína Morfogenética Ósea 2/administración & dosificación , Osificación Heterotópica/inducido químicamente , Osteoblastos/efectos de los fármacos , Osteogénesis/efectos de los fármacos , Inhibidores de Proteínas Quinasas/administración & dosificación , Piridinas/administración & dosificación , Quinasas Asociadas a rho/antagonistas & inhibidores , Animales , Animales Recién Nacidos , Proteína Morfogenética Ósea 4/genética , Diferenciación Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Células Cultivadas , Colágeno , Relación Dosis-Respuesta a Droga , Portadores de Fármacos , Humanos , Masculino , Ratones , Ratones Endogámicos ICR , Mutación , Osificación Heterotópica/enzimología , Osificación Heterotópica/fisiopatología , Osteoblastos/enzimología , Proyectos Piloto , ARN Mensajero/metabolismo , Proteínas Recombinantes/administración & dosificación , Cráneo/efectos de los fármacos , Cráneo/enzimología , Células del Estroma/efectos de los fármacos , Células del Estroma/enzimología , Transfección , Quinasas Asociadas a rho/genética , Quinasas Asociadas a rho/metabolismoRESUMEN
Mutations within the protein tyrosine phosphatase, SHP2, which is encoded by PTPN11, cause a significant proportion of Noonan syndrome (NS) cases, typically presenting with both cardiac disease and craniofacial abnormalities. Neural crest cells (NCCs) participate in both heart and skull formation, but the role of SHP2 signaling in NCC has not yet been determined. To gain insight into the role of SHP2 in NCC function, we ablated PTPN11 specifically in premigratory NCCs. SHP2-deficient NCCs initially exhibited normal migratory and proliferative patterns, but in the developing heart failed to migrate into the developing outflow tract. The embryos displayed persistent truncus arteriosus and abnormalities of the great vessels. The craniofacial deficits were even more pronounced, with large portions of the face and cranium affected, including the mandible and frontal and nasal bones. The data show that SHP2 activity in the NCC is essential for normal migration and differentiation into the diverse lineages found in the heart and skull and demonstrate the importance of NCC-based normal SHP2 activity in both heart and skull development, providing insight into the syndromic presentation characteristic of NS.